Life sciences news
-
Precigen ActoBio announces positive topline results from Phase 1b/2a Study of AG019 ActoBiotics™
Monday June 14th 2021
Read more
-
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Friday June 4th 2021
Read more
-
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
Wednesday May 19th 2021
Read more
-
Sequana Medical announces strong top-line results from RED DESERT alfapump DSR® study and expansion of DSR® development programme
Tuesday May 11th 2021
Read more
-
New cancer immunotherapy treatment enters clinical phase
Thursday April 29th 2021
Read more
-
Precirix partners with Evergreen to expand North American clinical trial supply
Wednesday April 28th 2021
Read more
-
ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version
Monday March 22nd 2021
Read more
-
Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million
Sunday March 21st 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos reports primary endpoint for the ongoing filgotinib MANTA and MANTA-RAy safety studies
Thursday March 4th 2021
Read more
-
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Thursday February 11th 2021
Read more
-
VUB scientist Mathieu Vinken coordinates prestigious European research into animal-free methods for testing chemical substances
Wednesday February 3rd 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
